perfluorobutane has been researched along with Disease Exacerbation in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Han, H; Jeong, DY; Kang, TW; Lee, MW; Lim, HK; Min, JH; Rhim, H; Sinn, DH; Song, KD | 1 |
Kato, T; Ohba, H; Oura, K; Terayama, Y | 1 |
Amanuma, M; Daido, Y; Igarashi, Y; Kobayashi, K; Kudo, T; Maruyama, K; Matsui, D; Matsui, T; Matsukiyo, Y; Momiyama, K; Mukozu, T; Nagai, H; Ogino, Y; Shinohara, M; Sumino, Y; Wakui, N; Yoshimine, N | 1 |
Higaki, A; Hirooka, M; Hyodo, T; Iijima, H; Imai, Y; Inoue, T; Koda, M; Korenaga, K; Kudo, M; Miyoshi, K; Murakami, T; Numata, K; Ochi, H; Suda, T; Takano, T; Tanaka, H | 1 |
Kudo, M | 1 |
Ichimori, M; Ishii, K; Kamiyama, N; Kanekawa, T; Otsuka, T; Shinohara, M; Sumino, Y; Takayama, R; Wakui, N | 1 |
Kikuchi, Y; Kudo, T; Maruyama, K; Shiozawa, K; Sumino, Y; Watanabe, M | 1 |
1 review(s) available for perfluorobutane and Disease Exacerbation
Article | Year |
---|---|
Multistep human hepatocarcinogenesis: correlation of imaging with pathology.
Topics: Angiography; Carcinoma, Hepatocellular; Disease Progression; Ferric Compounds; Gadolinium DTPA; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Oxides; Portography; Tomography, X-Ray Computed; Ultrasonography | 2009 |
6 other study(ies) available for perfluorobutane and Disease Exacerbation
Article | Year |
---|---|
Effect of Perfluorobutane Microbubbles on Radiofrequency Ablation for Hepatocellular Carcinoma: Suppression of Steam Popping and Its Clinical Implication.
Topics: Aged; Carcinoma, Hepatocellular; Case-Control Studies; Disease Progression; Disease-Free Survival; Female; Ferric Compounds; Fluorocarbons; Humans; Iron; Liver Neoplasms; Male; Microbubbles; Middle Aged; Oxides; Radiofrequency Ablation; Retrospective Studies; Treatment Outcome; Ultrasonography | 2020 |
Evaluation of Intraplaque Neovascularization Using Superb Microvascular Imaging and Contrast-Enhanced Ultrasonography.
Topics: Aged; Aged, 80 and over; Blood Flow Velocity; Carotid Arteries; Carotid Stenosis; Contrast Media; Disease Progression; Female; Ferric Compounds; Humans; Image Interpretation, Computer-Assisted; Iron; Male; Middle Aged; Neovascularization, Pathologic; Oxides; Perfusion Imaging; Plaque, Atherosclerotic; Predictive Value of Tests; Prognosis; Regional Blood Flow; Reproducibility of Results; Rupture, Spontaneous; Ultrasonography, Doppler; Video Recording | 2018 |
Flash Imaging Used in the Post-vascular Phase of Contrast-Enhanced Ultrasonography is Useful for Assessing the Progression in Patients with Hepatitis C Virus-Related Liver Disease.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Disease Progression; Female; Ferric Compounds; Hepatitis C, Chronic; Humans; Image Enhancement; Iron; Liver; Liver Cirrhosis; Male; Microbubbles; Middle Aged; Oxides; ROC Curve; Severity of Illness Index; Ultrasonography; Young Adult | 2019 |
Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Disease Progression; Female; Ferric Compounds; Gadolinium DTPA; Humans; Iron; Kaplan-Meier Estimate; Kupffer Cells; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neovascularization, Pathologic; Oxides; Retrospective Studies; Ultrasonography | 2016 |
Usefulness of arrival time parametric imaging in evaluating the degree of liver disease progression in chronic hepatitis C infection.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Contrast Media; Disease Progression; Female; Ferric Compounds; Hepatitis C, Chronic; Humans; Image Interpretation, Computer-Assisted; Infusions, Intravenous; Iron; Male; Middle Aged; Oxides; Platelet Count; Prothrombin Time; ROC Curve; Serum Albumin; Ultrasonography | 2012 |
Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: a pilot study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Contrast Media; Disease Progression; Ferric Compounds; Humans; Iron; Liver Neoplasms; Male; Middle Aged; Niacinamide; Oxides; Phenylurea Compounds; Pilot Projects; Predictive Value of Tests; Protein Kinase Inhibitors; Sorafenib; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2012 |